Procter & Gamble Health Ltd - Stock Valuation and Financial Performance

BSE: 500126 | NSE: PGHL | Pharmaceuticals & Drugs | Small Cap

Procter&Gamble Healt Share Price

4,781.90 -16.05 -0.33%
as on 12-Apr'24 16:59

DeciZen - make an informed investing decision on Procter&Gamble Healt

Overall Rating
Bole Toh

1. Quality

2. Valuation

Somewhat overvalued

3. Price Trend

Semi Strong

Procter & Gamble Health stock performance -

mw4me loader
P/E Ratio (SA):
35.02
Market Cap:
7,937.7 Cr.
52-wk low:
4,595.9
52-wk high:
5,640

Is Procter & Gamble Health Ltd an attractive stock to invest in?

1. Is Procter & Gamble Health Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Procter & Gamble Health Ltd is a good quality company.

2. Is Procter & Gamble Health Ltd undervalued or overvalued?

The key valuation ratios of Procter & Gamble Health Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Procter & Gamble Health Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Procter & Gamble Health Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Procter&Gamble Healt:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Procter & Gamble Health Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Jun'20Jun'21Jun'22Jun'23TTM
ROCE % 11%7.9%9.2%12.3%6.8%8.5%20.8%22.2%29.3%33.5%-
Value Creation
Index
-0.2-0.4-0.3-0.1-0.5-0.40.50.61.21.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 7988679409936988499041,0091,1141,2301,237
Sales YoY Gr.-8.7%8.3%5.7%-29.7%21.6%6.5%11.6%10.5%10.3%-
Adj EPS 33.425.531.746.628.858.1102.2107.1116.5137.8136.5
YoY Gr.--23.4%24.2%47.1%-38.3%102.1%75.9%4.8%8.8%18.3%-
BVPS (₹) 315.1333.9356.4399.9441.7927.8363.2421.6367447.6485.5
Adj Net
Profit
55.442.452.677.447.896.5170178193229227
Cash Flow from Ops. 0.5583.510753.7-130157247170236-
Debt/CF from Ops. 0000000000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 4.9%12%10.8%10.3%
Adj EPS 17.1%36.8%10.5%18.3%
BVPS4%0.3%7.2%22%
Share Price 21.7% 4.2% -8.5% -1.5%

Key Financial Parameters

Performance Ratio Colour Code Guide

Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Jun'20Jun'21Jun'22Jun'23TTM
Return on
Equity %
117.99.212.36.88.520.822.129.333.529.3
Op. Profit
Mgn %
9.76.8911.710.11723.424.524.126.425.5
Net Profit
Mgn %
6.94.95.67.86.811.418.817.617.418.618.3
Debt to
Equity
00000000000
Working Cap
Days
263274381367503486346491438423115
Cash Conv.
Cycle
74858266884912-3-22-3176

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 29.30%

Sales growth is growing at healthy rate in last 3 years 10.80%

Net Profit is growing at healthy rate in last 3 years 10.47%

Sales growth is not so good in last 4 quarters at 6.03%

Latest Financials - Procter & Gamble Health Ltd.

Standalone Consolidated
TTM EPS (₹) 136.5 -
TTM Sales (₹ Cr.) 1,237 -
BVPS (₹.) 485.5 -
Reserves (₹ Cr.) 789 -
P/BV 9.85 -
PE 35.02 -
From the Market
52 Week Low / High (₹) 4595.85 / 5640.00
All Time Low / High (₹) 114.00 / 7499.95
Market Cap (₹ Cr.) 7,938
Equity (₹ Cr.) 16.6
Face Value (₹) 10
Industry PE 48

Management X-Ray of Procter&Gamble Healt:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Procter&Gamble Healt

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSDec'13Dec'14Dec'15Dec'16Dec'17Dec'18Jun'20Jun'21Jun'22Jun'23
Sales7988679409936988491,3561,0091,1141,230
Operating Expenses 7218098568776287051,042763847905
Manufacturing Costs758486738185140139147139
Material Costs367405437412237269431312340362
Employee Cost 101114123154110131183154168206
Other Costs 178206210238200220287158193198
Operating Profit 77598311671144314246268325
Operating Profit Margin (%) 9.6%6.8%8.9%11.6%10.1%17.0%23.2%24.4%24.0%26.4%
Other Income 21202324302870181318
Interest 0000000101
Depreciation 10132325192129302728
Exceptional Items 00001770000
Profit Before Tax 88678311599158355233253314
Tax 322330363856101566185
Profit After Tax 5643547961102254177193229
PAT Margin (%) 7.0%5.0%5.7%8.0%8.7%12.0%18.7%17.5%17.3%18.7%
Adjusted EPS (₹)33.726.032.347.736.861.3153.1106.5116.0138.2
Dividend Payout Ratio (%)25%23%23%23%41%718%150%122%45%69%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSDec'13Dec'14Dec'15Dec'16Dec'17Dec'18Jun'20Jun'21Jun'22Jun'23

Equity and Liabilities

Shareholders Fund 5235545926647331,540904700609743
Share Capital 17171717171717171717
Reserves 5065385756477171,524888683593726
Minority Interest0000000000
Debt0000000000
Long Term Debt0000000000
Short Term Debt0000000000
Trade Payables364466758391124179172237
Others Liabilities 2136068686246999511,0841,0991,1571,253
Total Liabilities 7731,2041,5251,3631,5162,5832,1121,9781,9382,233

Fixed Assets

Gross Block197232271144192186200215241263
Accumulated Depreciation112122140255161102114131121
Net Fixed Assets8511013211914012498101110142
CWIP 92873091721394132
Investments 242442287000000
Inventories152177167164158113134118115135
Trade Receivables8410512710712366956083116
Cash Equivalents 1881641882792781,243639469325440
Others Assets2315978636367381,0181,1241,1911,2641,368
Total Assets 7731,2041,5251,3631,5162,5832,1121,9781,9382,233

Cash Flow

(All Figures are in Crores.)
PARTICULARSDec'13Dec'14Dec'15Dec'16Dec'17Dec'18Jun'20Jun'21Jun'22Jun'23
Cash Flow From Operating Activity 058310754-130235247170236
PBT 8867831151521,138355233253314
Adjustment 32116158-914-12412741
Changes in Working Capital -51-491630-47-50-641-47-30
Tax Paid -40-34-32-53-60-304-102-68-64-90
Cash Flow From Investing Activity 711-68-75-481,270165-32-26-22
Capex -33-40-45-32-10-19-23-51-38-38
Net Investments -132-39-59-57214124000
Others 42191616201,07564191216
Cash Flow From Financing Activity -5-17-12-15-22-30-883-387-289-98
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 0000000000
Dividend Paid -4-14-10-12-18-25-733-382-284-94
Others -1-2-2-3-4-5-150-5-5-5
Net Cash Flow 3-1417-161,109-483-172-145116
PARTICULARSDec'13Dec'14Dec'15Dec'16Dec'17Dec'18Jun'20Jun'21Jun'22Jun'23
Ratios
ROE (%)11.18.029.3512.618.748.9520.7922.0429.4133.94
ROCE (%)17.5312.3614.5418.3514.1613.929.0129.0838.4546.07
Asset Turnover Ratio0.920.910.710.710.490.410.580.490.60.64
PAT to CFO Conversion(x)00.121.541.350.89-1.270.931.40.881.03
Working Capital Days
Receivable Days33384341594122282227
Inventory Days62676459835833463634
Payable Days3735456111811691177189206

Procter & Gamble Health Ltd Stock News

Procter & Gamble Health Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Procter&Gamble Healt on 12-Apr-2024 16:59 is ₹4,781.9.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 12-Apr-2024 16:59 the market cap of Procter&Gamble Healt stood at ₹7,937.7.
The latest P/E ratio of Procter&Gamble Healt as of 12-Apr-2024 16:59 is 35.02.
The latest P/B ratio of Procter&Gamble Healt as of 12-Apr-2024 16:59 is 9.85.
The 52-week high of Procter&Gamble Healt is ₹5,640 and the 52-week low is ₹4,595.9.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Procter&Gamble Healt is ₹1,237 ( Cr.) .

About Procter & Gamble Health Ltd

Procter & Gamble Health Limited (formerly Merck Limited) was set up in India as one of Merck’s Asian subsidiaries in 1967.  It was also the first Merck Group Company to go public in the year 1981.  Till 2018, the Company was operating in all businesses included in the pharmaceuticals and chemicals businesses in the country.

On December 1st, 2018, P&G successfully completed the acquisition of Merck’s Consumer Health business further to approval of all relevant regulatory authorities and the fulfilment of other customary closing conditions. Procter & Gamble Overseas India B.V. now holds 51.81% of the share capital in Merck Limited, while the remaining 48.19% is traded on the Bombay Stock Exchange Ltd. and National Stock Exchange of India Ltd.

Currently, Procter & Gamble Health Limited (formerly Merck Limited) is one of India’s largest VMS Companies manufacturing and marketing over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle and improved quality of life. Its trusted products are household names in India protecting and supporting millions of people at every stage of life. With a strong portfolio of brands backed by science and trusted by doctors, pharmacists and consumers, Procter & Gamble Health Limited combines the best of P&G and Legacy Merck’s Consumer Health capabilities and cultures. Together we are working towards leveraging our combined expertise to develop categories and brands that meet today’s needs and tomorrow’s opportunities.

Situated at Usgaon, Goa, the company’s Manufacturing Site has grown from a small Vitamin E producing unit to a big composite plant manufacturing pharma and chemical products.

Business area of the company

Till 2018, the Company was operating in all businesses included in the pharmaceuticals and chemicals businesses in the country. The company is one of India’s largest VMS Companies manufacturing and marketing over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle and improved quality of life. Its trusted products are household names in India protecting and supporting millions of people at every stage of life.

Brands of the company

  • Neurobion
  • Evion
  • Seven Seas
  • Nasivion
  • Polybion
  • Livogen

Awards and achievements

  • 2015-16: Merck Goa plant was awarded 1st prize in safety called “Gomant Sarvochcha Suraksha Puraskar”. This is consecutive 2nd time Merck Goa plant bagged 1st prize in safety. Prior to that Merck Goa plant bagged 2nd prize in safety “Gomant Uchcha Suraksha Puraskar” for two consecutive years.
  • 2016-17: Consumer activation done for Neurobion under ‘True Heroes’ campaign won laurels at the Global level to receive President’s Award in 2017.
  • 2017-18: Nasivion continued to be the Doctors’ trusted No. 1 Nasal Decongestant.
  • 2019-20: Neurobion bagged three awards viz. Nicholas Hall Marketing Excellence Award; CIMS Trusted Brand of the Year; and ABP News Brand Excellence Award.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.